Scope of homoeopathic medicine in influenza

Phase 3

Completed

• Conditions: Influenza like illness.

• Registration Number: CTRI/2012/04/002590
• Lead Sponsor: Central Council for Research in Homoeopathy New Delhi

Brief Summary

A multicentric randomized, placebo controlled study on effect of individualized homoeopathic treatment on Influenza like illness shall be carried out by Central Council for Research in Homeopathy at its various Institutes/ Units throughout India. Participants shall be selected from both sexes, age ranging between 12-60 years presenting with signs and symptoms of Influenza like illness. Visual analog scale (VAS) ranging from 0-10 shall be used for assessing headache, myalgia, malaise, throat pain, nasal complaints, chill and sweat. Cough shall be measured with scale developed by Hsu et al. The data generated shall be assessed using SPSS statistical package, version 16 and the results shall be disseminated to the medical fraternity.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08-06
• Last Update Posted: 2012-03-30

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 432

Inclusion Criteria

• Patients meet all of the following criteria shall be eligible for study participation: Patients of either sex, age group 12-60 years, presenting to study physician within 36hrs of onset of symptoms.
• Patients presenting with signs/symptoms of influenza like illnesses: Abrupt onset of fever (≥100.4°F or 38oC body temp.) with at least one respiratory symptom ï›cough, sore throat, or nasal symptom (discharge, obstruction)ï and at least one constitutional symptom (headache, malaise, myalgia, sweats or chills, or fatigue).

Exclusion Criteria

• Patients meeting any of the following criteria shall be excluded: •Who have received other medication (anti-viral) within the 36 hours before entry into the study.
• •Patients who had immunization against influenza or influenza like illnessess for that season.
• •Inability to comply with the study protocol, including psychiatric diseases.
• •Immune compromised or with other clinically active illness including cardiac or pulmonary diseases, hemoglobinopathies, renal dysfunction.
• •Pregnant women.
• •Lactating mother.
• •History of drug or alcohol abuse.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate effect of Homoeopathic medicines in the treatment of influenza like illness.	2 years

Secondary Outcome Measures

Name	Time	Method
To caopare the complication rate among patients receiving homoeopathic medication as compare to the complication rate in patients receiving placebo.	To compare the efficacy of LM potency vis-a-vis Centesimal potency

Trial Locations

Locations (9)

Central Research Institute(H), A-1/1. Sector-24,; 🇮🇳 Nagar, UTTAR PRADESH, India

Clinical Research Unit (H),; 🇮🇳 NICOBAR, NICOBAR ISLANDS, India

Clinical Research Unit(H),; 🇮🇳 Chennai, TAMIL NADU, India

Clinical Research Unit(T) for Homoeopathy,; 🇮🇳 Darjiling, WEST BENGAL, India

Drug Standardisation Unit(H),; 🇮🇳 Hyderabad, ANDHRA PRADESH, India

Regional Research Inst. (H),; 🇮🇳 Puri, ORISSA, India

Regional Research Inst. (H), Opp. Palace Compound; 🇮🇳 East, MANIPUR, India

Regional Research Institute (H), Rabha Bhawan, Khalipara, Odel Bakara, Guwahati (Assam)-7810034; 🇮🇳 Kamrup, ASSAM, India

Regional Research Institute for Homoeopathy; 🇮🇳 Kolkata, WEST BENGAL, India

Central Research Institute(H), A-1/1. Sector-24,

🇮🇳Nagar, UTTAR PRADESH, India

DrKumar vivekanand

Principal investigator

crihnoida@gmail.com